CASE STUDIES

33% Revenue Growth with Named Patient Program

COMMERCIAL PLANNING

How the Head of Global Market Access for an oral oncolytic was able to increase revenue potential by thinking outside the U.S.

Alternate Site of Care Market and Strategy
PHARMACY
Webinar Archive: Four essential steps to creating a patient support HUB that meets the unique needs of a manufacturer’s patients and prescribers.
Assessment of Hybrid HUB Enables Optimization
ACCESS AND AFFORDABILITY
How a thorough assessment of a manufacturer’s patient services department helped optimize a Hybrid HUB for future success.
Cell Therapy Commercial Supply Chain

DISTRIBUTION

How a U.S. biotech company established a global supply chain for a cell therapy with complicated and unique characteristics.
Commercial Channel
Strategy
DISTRIBUTION
How a young biotech company with only a handful of employees was fully contracted and on schedule to implement in advance of launch.
Commercial Operations Assessment Drives Efficiencies
ACCESS AND AFFORDABILITY
How a mid-sized manufacturer’s commercial operations team increased efficiency and drove future scalability with a comprehensive third-party assessment.
DSA Optimization
Saves $2.7M
DISTRIBUTION
How a growing manufacturer identified $2.7M in savings with a thorough analysis of their existing Distribution Service Agreements.
Data
Accuracy
COMMERCIAL PLANNING
How one manufacturer is now leveraging more accurate, meaningful, and actionable data to make strategic decisions.
Data Aggregator Strategy and Selection

COMMERCIAL PLANNING

How a young biotech company successfully integrated data across seven external vendors

Digitalization
Implementation

ACCESS AND AFFORDABILITY

How a large manufacturer accelerated time to therapy with a full suite of digitalized services.

Distribution Fee Assessment Guides Negotiations
DISTRIBUTION
How a large manufacturer was able to leverage benchmark fee ranges to better negotiate distribution agreements.
Distribution Strategy Mapped for Complex Oncolytic
DISTRIBUTION
How a pharmaceutical company determined the best distribution strategy for a challenging oncology product.

Distributor Contract Positions Validated

DISTRIBUTION
How a small pharmaceutical manufacturer realized significant savings following a review of distribution partner contracts.
Enhanced Notifications to Field Access Reimbursement Specialists Improves Customer Education Timeliness
ACCESS AND AFFORDABILITY
How a manufacturer was able to design and implement an enhanced platform for Field Reimbursement Specialists to reduce case barriers and improve medication fulfillment rates.
European Advisory
Board

COMMERCIAL PLANNING

How an US-based cell therapy company overcame a tight timeline to gain insights from key stakeholders across 5 European markets.

HUB Overhaul Saves 25%; Sales Increase 34%
ACCESS AND AFFORDABILITY

How a pharmaceutical company revamped an old, inefficient HUB model to save 1/4 of their annual budget and increase sales by 1/3.

Hub Launch Team
Extension
ACCESS AND AFFORDABILITY
How a manufacturer successfully prepared for a hybrid HUB launch by temporarily extending their team’s expertise.
Integrated Specialty Pharmacy Market Assessment
PHARMACY
How a thorough assessment of a hospital system specialty pharmacy helped optimize its value proposition and capabilities for future success.
Internal HUB
Optimization
ACCESS AND AFFORDABILITY
How one manufacturer decreased time to fill by 2 months and boosted incremental revenue by $15M.
LDD SP for Rare Disease
PHARMACY
How a manufacturer was able to align multiple stakeholder needs to select the best Limited Distribution Specialty Pharmacy for their rare disease product
Major Reduction in Aged Specialty Pharmacy Pending Referrals Drives $11M+ in Revenue
PHARMACY
How a manufacturer was able to rescue 25% of pending referrals in less than 2 months, amounting to an initial $11M revenue boost
Manufacturer Buys Stagnant Brands for Relaunch
DISTRIBUTION
How a new manufacturer successfully relaunched a stagnant product line with limited trade and distribution staff and experience.
Market Analysis Informs Biotech Distribution Strategy
COMMERCIAL PLANNING
How a biotech company was able to quickly understand the retinal landscape to build a commercial distribution strategy for their first launch.
Market Research Guides Gene Therapy Commercial Strategy
COMMERCIAL PLANNING
How a biotech company was able to identify and address potential future commercial operational complexities early in clinical development.
Market Research Identifies Barriers to Cell Therapy Commercialization
COMMERCIAL PLANNING
How a manufacturer was able to identify and correct significant site of care issues ahead of launch.
Patient And Provider Escalation Support
ACCESS AND AFFORDABILITY
How a small biotech successfully managed escalations around launch without adding staff.
Patient Services Optimization Guides Program Improvements
ACCESS AND AFFORDABILITY
How a manufacturer was able to systematically assess and address Patient Services Program performance issues
Patient Services Product Launch
ACCESS AND AFFORDABILITY
How a large, global manufacturer successfully managed a patient support launch strategy in a crowded specialty market on time and under budget.
Patient Support Program Optimized with Market Research Insights
ACCESS AND AFFORDABILITY
How an established patient support program was able to identify and overcome design barriers to stimulate access.
Patient Support Services Model Pressure Tested and Validated
ACCESS AND AFFORDABILITY
How a large manufacturer was able to identify additional access drivers for a PSP model design ahead of launch, while securing essential internal stakeholder support.
Prescription Digital Therapeutic (PDT) Distribution Strategy
DISTRIBUTION
How one manufacturer is optimally positioned for distribution success ahead of its Prescription Digital Therapeutic (PDT) launch
Quality Enhances Customer Experience
ACCESS AND AFFORDABILITY
How implementing a Quality Management System helped a Brand team improve benefit verification accuracy by 4.8% in 2 months.
Resource Support for Mfr’s Patient Services Team
ACCESS AND AFFORDABILITY
How one manufacturer implemented several patient support initiatives over a 6-month period by bringing on temporary skilled staffing support.
SP Network for Oral Oncolytic with OTC Companion Needs
PHARMACY
How a new oncology therapy used a well-designed SP network to overcome AE concerns and exceed sales expectations.
Smart Program Evaluation & Contracting
COMMERCIAL PLANNING
How one manufacturer leveraged smart contracting to find innovation and flexibility alongside efficiencies and overall savings.
Strategic Selection of Third Party Logistics Partner
DISTRIBUTION
How a manufacturer selected a 3PL partner best suited to the unique needs of their product and immediately began preparing for launch.
Successful Distribution Commercial Launch
DISTRIBUTION
How an emerging manufacturer was able to launch their first drug on-time with relatively few issues, given a short runway and resource constraints.
Support Services at SP for Complex Pediatric Product
ACCESS AND AFFORDABILITY
How a mid-sized manufacturer met the complex needs of their pediatric product’s stakeholders by placing support services at the SP, instead of the HUB
Transitioning HUB from Insourced to Outsourced
ACCESS AND AFFORDABILITY
How a large manufacturer successfully transitioned an internal, 5-product HUB to a third-party vendor on schedule.
Understanding COVID-19 Impacts to Logistics
DISTRIBUTION
How a cell therapy manufacturer was able to avoid COVID-19 disruptions to their distribution model.

SUBSCRIBE

Subscribe to receive news and updates from Archbow Consulting